Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Prieto

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 16, 2004
Association of adenylate cyclase with an actin-like protein in the human myometriumA M Bajo, J C Prieto, P Valenzuela, et al.
Biology of the Neonate|January 1, 1988
Interaction of insulin with small intestinal epithelial cells from developing ratsM D Fernández-Moreno, M A Fernández-González, J L Diaz-Juárez, et al.
Cellular Signalling|May 24, 2000
Effect of flutamide-induced androgen-receptor blockade on adenylate cyclase activation through G-protein coupled receptors in rat prostateL Montalvo, M J Carmena, R M Solano, et al.
Tissue & Cell|February 24, 2001
Impairment of adenylate cyclase activity and G-proteins in human uterine leiomyomaA Bajo, I Carrero, R L Hrïstov, et al.
The Journal of Urology|November 7, 2001
Low expression of Galpha protein subunits in human prostate cancerM O García-Fernández, R M Solano, M Sánchez-Chapado, et al.
Archives of Toxicology|November 7, 1998
Cyclosporin A induces apoptosis in rat hepatocytes in cultureI D Román, N Rodríguez-Henche, J A Fueyo, et al.
General Pharmacology|January 1, 1987
Tissue and plasma distribution of exogenous growth hormone-releasing factor analogue (GRF1-29NH2) after intravenous, subcutaneous and intraperitoneal injection in the ratM A Fernandez-Gonzalez, V Barrios, J I Sancho, et al.
Revista Medica De Chile|July 1, 1990
[Antitubercular agents: pharmacogenetic factors in the development of adverse effects]M Ligueros, H Saavedra, S Neira, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
Receptors for pituitary adenylate cyclase-activating peptide in human liverL G Guijarro, N Rodriguez-Henche, E García-López, et al.
FEBS Letters|April 7, 1997
Identification of a protein-tyrosine phosphatase (SHP1) different from that associated with acid phosphatase in rat prostateA M Valencia, J L Oliva, G Bodega, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 16, 2004
Association of adenylate cyclase with an actin-like protein in the human myometriumA M Bajo, J C Prieto, P Valenzuela, et al.
Biology of the Neonate|January 1, 1988
Interaction of insulin with small intestinal epithelial cells from developing ratsM D Fernández-Moreno, M A Fernández-González, J L Diaz-Juárez, et al.
Cellular Signalling|May 24, 2000
Effect of flutamide-induced androgen-receptor blockade on adenylate cyclase activation through G-protein coupled receptors in rat prostateL Montalvo, M J Carmena, R M Solano, et al.
Tissue & Cell|February 24, 2001
Impairment of adenylate cyclase activity and G-proteins in human uterine leiomyomaA Bajo, I Carrero, R L Hrïstov, et al.
The Journal of Urology|November 7, 2001
Low expression of Galpha protein subunits in human prostate cancerM O García-Fernández, R M Solano, M Sánchez-Chapado, et al.
Archives of Toxicology|November 7, 1998
Cyclosporin A induces apoptosis in rat hepatocytes in cultureI D Román, N Rodríguez-Henche, J A Fueyo, et al.
General Pharmacology|January 1, 1987
Tissue and plasma distribution of exogenous growth hormone-releasing factor analogue (GRF1-29NH2) after intravenous, subcutaneous and intraperitoneal injection in the ratM A Fernandez-Gonzalez, V Barrios, J I Sancho, et al.
Revista Medica De Chile|July 1, 1990
[Antitubercular agents: pharmacogenetic factors in the development of adverse effects]M Ligueros, H Saavedra, S Neira, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
Receptors for pituitary adenylate cyclase-activating peptide in human liverL G Guijarro, N Rodriguez-Henche, E García-López, et al.
FEBS Letters|April 7, 1997
Identification of a protein-tyrosine phosphatase (SHP1) different from that associated with acid phosphatase in rat prostateA M Valencia, J L Oliva, G Bodega, et al.
Pageof 18